Počet záznamov: 1  

Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherpy of unresectable liver metastases in colorectal cancer patients

  1. SYS0005537
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20181219130948.4
    100
      
    $a 20080213a2008 m y0sloy0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherpy of unresectable liver metastases in colorectal cancer patients $f U. Coskun ... [et al.]
    215
      
    $c ilustr., grafy, tab.
    320
      
    $a Bibliogr. odkazy
    320
      
    $a Res. angl.
    463
    -1
    $1 001 sllk_un_cat*0005116 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 55, no. 1 (2008), s. 65-70 $1 210 $a Bratislava $c AEPress $d 2008 $1 215 $a s. 1-80
    541
    1-
    $a Xelox (capecitabine a oxaliplatina) ako neoadjuvantná chemoterapia neresekovateľných metastáz v pečeni u pacientov s kolorektálnou rakovinou $z slo
    606
    1-
    $3 sllk_un_auth*d015179 $a nádory kolorektálne $x komplikácie $2 mesh
    606
    1-
    $3 sllk_un_auth*d008113 $a nádory pečene $x sekundárne $2 mesh
    606
    1-
    $3 sllk_un_auth*d009362 $a metastázy nádorové $x farmakoterapia $x terapia $2 mesh
    606
    2-
    $3 sllk_un_auth*d020360 $a terapia neoadjuvantná $2 mesh
    606
    2-
    $3 sllk_un_auth*d000970 $a antineoplastiká $x použitie terapeutické $x toxicita $x účinky nežiaduce $2 mesh
    606
    2-
    $3 sllk_un_auth*d009944 $a zlúčeniny organoplatinové $x použitie terapeutické $2 mesh
    606
    2-
    $3 sllk_un_auth*d017741 $a preživší $x štatistika a číselné údaje $2 mesh
    610
    2-
    $a metastázy pečeňové
    610
    2-
    $a chemoterapia neoadjuvantná
    610
    2-
    $a režim XELOX
    675
      
    $a 616.348/.35-006-06 $v UDC-MRF-SK3 $z slo
    675
      
    $a 616.36-033.2-085 $v UDC-MRF-SK3 $z slo
    675
      
    $a 615.277 $v UDC-MRF-SK3 $z slo
    701
    -1
    $3 sllk_un_auth*p0066022 $a Coskun $b U. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0001869 $a Buyukberber $b S. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0001870 $a Yaman $b E. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*p0037000 $a Uner $b A. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0001876 $a Er $b O. $4 070 $p Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey
    701
    -1
    $3 sllk_un_auth*0001877 $a Ozkan $b M. $4 070 $p Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey
    701
    -1
    $3 sllk_un_auth*0001878 $a Dikilitas $b M. $4 070 $p Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey
    701
    -1
    $3 sllk_un_auth*0001875 $a Oguz $b M. $4 070 $p Gazi University Medical School, Departments of Medical Surgery, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0001871 $a Yildiz $b R. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*p0031810 $a Yamac $b D. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0001872 $a Ozturk $b B. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0001873 $a Kaya $b A. O. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    701
    -1
    $3 sllk_un_auth*0001885 $a Benekli $b M. $4 070 $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey
    801
    -0
    $a SK $b BA006 $c 20080213 $g AACR2
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.